88 related articles for article (PubMed ID: 29121955)
1. Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro.
Herrera-Gayol A; Jothy S
Int J Exp Pathol; 2001 Jun; 82(3):193-200. PubMed ID: 11488992
[TBL] [Abstract][Full Text] [Related]
2. CD44 mediates stem cell mobilization to damaged lung
Ouhtit A; Thouta R; Zayed H; Gaur RL; Fernando A; Rahman M; Welsh DA
Int J Med Sci; 2020; 17(1):103-111. PubMed ID: 31929744
[TBL] [Abstract][Full Text] [Related]
3. CD146, a therapeutic target involved in cell plasticity.
Wu Z; Zang Y; Li C; He Z; Liu J; Du Z; Ma X; Jing L; Duan H; Feng J; Yan X
Sci China Life Sci; 2024 Apr; ():. PubMed ID: 38613742
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
[TBL] [Abstract][Full Text] [Related]
5. CD146, from a melanoma cell adhesion molecule to a signaling receptor.
Wang Z; Xu Q; Zhang N; Du X; Xu G; Yan X
Signal Transduct Target Ther; 2020 Aug; 5(1):148. PubMed ID: 32782280
[TBL] [Abstract][Full Text] [Related]
6. Structure basis for AA98 inhibition on the activation of endothelial cells mediated by CD146.
Chen X; Yan H; Liu D; Xu Q; Duan H; Feng J; Yan X; Xie C
iScience; 2021 May; 24(5):102417. PubMed ID: 33997697
[TBL] [Abstract][Full Text] [Related]
7. Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis-Contribution of New Antibodies for Therapy.
Joshkon A; Heim X; Dubrou C; Bachelier R; Traboulsi W; Stalin J; Fayyad-Kazan H; Badran B; Foucault-Bertaud A; Leroyer AS; Bardin N; Blot-Chabaud M
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33352759
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.
Zoni E; Astrologo L; Ng CKY; Piscuoglio S; Melsen J; Grosjean J; Klima I; Chen L; Snaar-Jagalska EB; Flanagan K; van der Pluijm G; Kloen P; Cecchini MG; Kruithof-de Julio M; Thalmann GN
Mol Cancer Res; 2019 May; 17(5):1049-1062. PubMed ID: 30745464
[TBL] [Abstract][Full Text] [Related]
9. CD146-targeted nuclear medicine imaging in cancer: state of the art.
Yang Q; Huang W; Hsu JC; Song L; Sun X; Li C; Cai W; Kang L
View (Beijing); 2023 Oct; 4(5):. PubMed ID: 38076327
[TBL] [Abstract][Full Text] [Related]
10. CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway.
Chen J; Xu Q; Liu D; Li X; Guo M; Chen X; Liao J; Lei R; Li W; Huang H; Saw PE; Song E; Yan X; Nie Y
Cancer Commun (Lond); 2023 Nov; 43(11):1244-1266. PubMed ID: 37856423
[TBL] [Abstract][Full Text] [Related]
11. Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition.
Mannion AJ; Odell AF; Baker SM; Matthews LC; Jones PF; Cook GP
Front Cell Dev Biol; 2023; 11():1129015. PubMed ID: 37138793
[TBL] [Abstract][Full Text] [Related]
12.
Alateyah N; Gupta I; Rusyniak RS; Ouhtit A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164076
[TBL] [Abstract][Full Text] [Related]
13. Recognize the role of CD146/MCAM in the osteosarcoma progression: an in vitro study.
Lei X; Wang K; Wang W; Jin H; Gu W; Chen Z; Wang W; Gao K; Wang H
Cancer Cell Int; 2021 Jun; 21(1):300. PubMed ID: 34103063
[TBL] [Abstract][Full Text] [Related]
14. Remodelling of the bone marrow microenvironment by stromal hyaluronan modulates the malignancy of breast cancer cells.
Chen X; Shi X; Liu Y; He Y; Du Y; Zhang G; Yang C; Gao F
Cell Commun Signal; 2020 Jun; 18(1):89. PubMed ID: 32517712
[TBL] [Abstract][Full Text] [Related]
15. Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer.
Alt EU; Wörner PM; Pfnür A; Ochoa JE; Schächtele DJ; Barabadi Z; Lang LM; Srivastav S; Burow ME; Chandrasekar B; Izadpanah R
Sci Rep; 2020 Jun; 10(1):8834. PubMed ID: 32483202
[TBL] [Abstract][Full Text] [Related]
16. Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines.
Bonfim-Silva R; Salomão KB; Pimentel TVCA; Menezes CCBO; Palma PVB; Fontes AM
Cytotechnology; 2019 Oct; 71(5):893-903. PubMed ID: 31346954
[TBL] [Abstract][Full Text] [Related]
17. CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion.
Ouhtit A; Abdraboh ME; Hollenbach AD; Zayed H; Raj MHG
Cell Commun Signal; 2017 Nov; 15(1):45. PubMed ID: 29121955
[TBL] [Abstract][Full Text] [Related]
18. Novel CD44-downstream signaling pathways mediating breast tumor invasion.
Ouhtit A; Rizeq B; Saleh HA; Rahman MM; Zayed H
Int J Biol Sci; 2018; 14(13):1782-1790. PubMed ID: 30443182
[TBL] [Abstract][Full Text] [Related]
19. Survivin is a novel target of CD44-promoted breast tumor invasion.
Abdraboh ME; Gaur RL; Hollenbach AD; Sandquist D; Raj MH; Ouhtit A
Am J Pathol; 2011 Aug; 179(2):555-63. PubMed ID: 21718681
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
